Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 11 January 1985:
Vol. 227. no. 4683, pp. 171 - 173
DOI: 10.1126/science.2981427
Prev | Table of Contents | Next

Articles

Science, Vol 227, Issue 4683, 171-173
Copyright © 1985 by American Association for the Advancement of Science

articles

Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat

J Sodroski, C Rosen, F Wong-Staal, SZ Salahuddin, M Popovic, S Arya, RC Gallo, and WA Haseltine

Human T-cell leukemia virus type III (HTLV-III) was recently identified as the probable etiologic agent of the acquired immune deficiency syndrome (AIDS). Here it is shown that, in human T-cell lines infected with HTLV-III, gene expression directed by the long terminal repeat sequence of this virus is stimulated by more than two orders of magnitude compared to matched uninfected cells. The rate of transcription of the HTLV-III long terminal repeat is more than 1000 times that of the SV40 early promoter in one infected cell line. Thus, HTLV-III, like HTLV-I, HTLV-II, and the bovine leukemia virus, is characterized by trans-activation of transcription in infected cells. The efficiency of trans-activation in the case of HTLV-III may account, at least in part, for the virulent nature of HTLV-III infection.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
HIV-1 Tat Mediates Degradation of RON Receptor Tyrosine Kinase, a Regulator of Inflammation.
P. Kalantari, O. F. Harandi, P. A. Hankey, and A. J. Henderson (2008)
J. Immunol. 181, 1548-1555
   Abstract »    Full Text »    PDF »
Crystal Structures of HIV-1 Tat-derived Nonapeptides Tat-(1-9) and Trp2-Tat-(1-9) Bound to the Active Site of Dipeptidyl-peptidase IV (CD26).
W. A. Weihofen, J. Liu, W. Reutter, W. Saenger, and H. Fan (2005)
J. Biol. Chem. 280, 14911-14917
   Abstract »    Full Text »    PDF »
Bis-Anthracycline Antibiotics Inhibit Human Immunodeficiency Virus Type 1 Transcription.
O. Kutsch, D. N. Levy, P. J. Bates, J. Decker, B. R. Kosloff, G. M. Shaw, W. Priebe, and E. N. Benveniste (2004)
Antimicrob. Agents Chemother. 48, 1652-1663
   Abstract »    Full Text »    PDF »
Stimulation of Tat-independent transcriptional processivity from the HIV-1 LTR promoter by matrix attachment regions.
S. Rampalli, A. Kulkarni, P. Kumar, D. Mogare, S. Galande, D. Mitra, and S. Chattopadhyay (2003)
Nucleic Acids Res. 31, 3248-3256
   Abstract »    Full Text »    PDF »
HIV-1 Tat Protein-mediated Transactivation of the HIV-1 Long Terminal Repeat Promoter Is Potentiated by a Novel Nuclear Tat-interacting Protein of 110 kDa, Tip110.
Y. Liu, J. Li, B. O. Kim, B. S. Pace, and J. J. He (2002)
J. Biol. Chem. 277, 23854-23863
   Abstract »    Full Text »    PDF »
Outcome of Simian-Human Immunodeficiency Virus Strain 89.6p Challenge following Vaccination of Rhesus Macaques with Human Immunodeficiency Virus Tat Protein.
P. Silvera, M. W. Richardson, J. Greenhouse, J. Yalley-Ogunro, N. Shaw, J. Mirchandani, K. Khalili, J.-F. Zagury, M. G. Lewis, and J. Rappaport (2002)
J. Virol. 76, 3800-3809
   Abstract »    Full Text »    PDF »
Increased Level of Stromal Cell-Derived Factor-1 mRNA in Peripheral Blood Mononuclear Cells from Children with AIDS-related Lymphoma.
S. Sei, D. P. O'Neill, S. K. Stewart, Q.-e. Yang, M. Kumagai, A. M. Boler, M. A. Adde, S. L. Zwerski, L. V. Wood, D. J. Venzon, et al. (2001)
Cancer Res. 61, 5028-5037
   Abstract »    Full Text »    PDF »
Development of lentiviral vectors for gene therapy for human diseases.
G. L. Buchschacher Jr and F. Wong-Staal (2000)
Blood 95, 2499-2504
   Abstract »    Full Text »    PDF »
Human T-Cell Leukemia Virus Type 1 Tax Shuttles between Functionally Discrete Subcellular Targets.
M. Burton, C. D. Upadhyaya, B. Maier, T. J. Hope, and O. J. Semmes (2000)
J. Virol. 74, 2351-2364
   Abstract »    Full Text »
A Second Target for the Peptoid Tat/Transactivation Response Element Inhibitor CGP64222: Inhibition of Human Immunodeficiency Virus Replication by Blocking CXC-Chemokine Receptor 4-Mediated Virus Entry.
D. Daelemans, D. Schols, M. Witvrouw, C. Pannecouque, S. Hatse, S. van Dooren, F. Hamy, T. Klimkait, E. de Clercq, and A.-M. VanDamme (2000)
Mol. Pharmacol. 57, 116-124
   Abstract »    Full Text »
Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Functions as an Immediate-Early Protein during HIV-1 Infection.
M. Hrimech, X.-J. Yao, F. Bachand, N. Rougeau, and E. A. Cohen (1999)
J. Virol. 73, 4101-4109
   Abstract »    Full Text »
The Basic Domain in HIV-1 Tat Protein as a Target for Polysulfonated Heparin-mimicking Extracellular Tat Antagonists.
M. Rusnati, G. Tulipano, C. Urbinati, E. Tanghetti, R. Giuliani, M. Giacca, M. Ciomei, A. Corallini, and M. Presta (1998)
J. Biol. Chem. 273, 16027-16037
   Abstract »    Full Text »    PDF »
S-Adenosylhomocysteine Hydrolase Inhibitors Interfere with the Replication of Human Immunodeficiency Virus Type 1 through Inhibition of the LTR Transactivation.
D. Daelemans, J. A. Esté, M. Witvrouw, C. Pannecouque, H. Jonckheere, S. Aquaro, C.-F. Perno, E. D. Clercq, and A.-M. Vandamme (1997)
Mol. Pharmacol. 52, 1157-1163
   Abstract »    Full Text »
The N-terminal Structure of HIV-1 Tat Is Required for Suppression of CD26-dependent T Cell Growth.
S. Wrenger, T. Hoffmann, J. Faust, C. Mrestani-Klaus, W. Brandt, K. Neubert, M. Kraft, S. Olek, R. Frank, S. Ansorge, et al. (1997)
J. Biol. Chem. 272, 30283-30288
   Abstract »    Full Text »    PDF »
Interaction of HIV-1 Tat Protein with Heparin. ROLE OF THE BACKBONE STRUCTURE, SULFATION, AND SIZE.
M. Rusnati, D. Coltrini, P. Oreste, G. Zoppetti, A. Albini, D. Noonan, F. d'A. di Fagagna, M. Giacca, and M. Presta (1997)
J. Biol. Chem. 272, 11313-11320
   Abstract »    Full Text »    PDF »
HIV-1 Protein Expression from Synthetic Circles of DNA Mimicking the Extrachromosomal Forms of Viral DNA.
A. Cara, A. Cereseto, F. Lori, and M. S. Reitz Jr. (1996)
J. Biol. Chem. 271, 5393-5397
   Abstract »    Full Text »    PDF »
The HIV-1 TAT Protein Induces the Expression and Extracellular Appearance of Acidic Fibroblast Growth Factor.
S. R. Opalenik, J. T. Shin, J. N. Wehby, V. K. Mahesh, and J. A. Thompson (1995)
J. Biol. Chem. 270, 17457-17467
   Abstract »    Full Text »    PDF »
Molecular Targets of Gene Transfer Therapy for HIV Infection.
G. L. Buchschacher Jr (1993)
JAMA 269, 2880-2886
   Abstract »    PDF »
Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist.
M. Hsu, A. Schutt, M Holly, L. Slice, M. Sherman, D. Richman, M. Potash, and D. Volsky (1991)
Science 254, 1799-1802
   Abstract »    PDF »
Cutaneous T-Cell Lymphoma and Human Immunodeficiency Virus: The Spectrum Broadens.
P. L. Myskowski (1991)
Arch Dermatol 127, 1045-1047
   Abstract »    PDF »
Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs..
S J Arrigo and I S Chen (1991)
Genes & Dev. 5, 808-819
   Abstract »    PDF »
Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition..
B J Calnan, S Biancalana, D Hudson, and A D Frankel (1991)
Genes & Dev. 5, 201-210
   Abstract »    PDF »
Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation..
M F Laspia, A P Rice, and M B Mathews (1990)
Genes & Dev. 4, 2397-2408
   Abstract »    PDF »
Molecular targets for AIDS therapy.
H Mitsuya, R Yarchoan, and S Broder (1990)
Science 249, 1533-1544
   Abstract »    PDF »
A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation..
S Roy, U Delling, C H Chen, C A Rosen, and N Sonenberg (1990)
Genes & Dev. 4, 1365-1373
   Abstract »    PDF »
A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator.
P Nelbock, P. Dillon, A Perkins, and C. Rosen (1990)
Science 248, 1650-1653
   Abstract »    PDF »
Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product.
S Roy, M. Katze, N. Parkin, I Edery, A. Hovanessian, and N Sonenberg (1990)
Science 247, 1216-1219
   Abstract »    PDF »
Secondary structure is the major determinant for interaction of HIV rev protein with RNA.
H. Olsen, P Nelbock, A. Cochrane, and C. Rosen (1990)
Science 247, 845-848
   Abstract »    PDF »
Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.
R. Viscidi, K Mayur, H. Lederman, and A. Frankel (1989)
Science 246, 1606-1608
   Abstract »    PDF »
Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells.
C. Hart, C. Ou, J. Galphin, J Moore, L. Bacheler, J. Wasmuth, S. Petteway Jr, and G Schochetman (1989)
Science 246, 488-491
   Abstract »    PDF »
Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements..
S M Hanly, L T Rimsky, M H Malim, J H Kim, J Hauber, M Duc Dodon, S Y Le, J V Maizel, B R Cullen, and W C Greene (1989)
Genes & Dev. 3, 1534-1544
   Abstract »    PDF »
Regulation of HIV and HTLV gene expression..
H Varmus (1988)
Genes & Dev. 2, 1055-1062
   PDF »
Tat protein from human immunodeficiency virus forms a metal-linked dimer.
A. Frankel, D. Bredt, and C. Pabo (1988)
Science 240, 70-73
   Abstract »    PDF »
A quantitative bioassay for HIV-1 based on trans-activation.
B. Felber and G. Pavlakis (1988)
Science 239, 184-187
   Abstract »    PDF »
Expression of the art/trs protein of HIV and study of its role in viral envelope synthesis.
D. Knight, F. Flomerfelt, and J Ghrayeb (1987)
Science 236, 837-840
   Abstract »    PDF »
Expression and characterization of the trans-activator of HTLV-III/LAV virus.
C. Wright, B. Felber, H Paskalis, and G. Pavlakis (1986)
Science 234, 988-992
   Abstract »    PDF »
In vivo competition between a metallothionein regulatory element and the SV40 enhancer.
H Scholer, A Haslinger, A Heguy, H Holtgreve, and M Karin (1986)
Science 232, 76-80
   Abstract »    PDF »
Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.
J Sodroski, W. Goh, C Rosen, A Tartar, D Portetelle, A Burny, and W Haseltine (1986)
Science 231, 1549-1553
   Abstract »    PDF »
Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera.
N. Kan, G Franchini, F Wong-Staal, G. DuBois, W. Robey, J. Lautenberger, and T. Papas (1986)
Science 231, 1553-1555
   Abstract »    PDF »
Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS.
D Zagury, J Bernard, R Leonard, R Cheynier, M Feldman, P. Sarin, and R. Gallo (1986)
Science 231, 850-853
   Abstract »    PDF »
The action of oncogenes in the cytoplasm and nucleus.
R. Weinberg (1985)
Science 230, 770-776
   Abstract »    PDF »
A Human T-Lymphotropic Retrovirus (HTLV-III) as the Cause of the Acquired Immunodeficiency Syndrome.
R. C. GALLO and F. WONG-STAAL (1985)
Ann Intern Med 103, 679-689
   Abstract »    PDF »
The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats.
B. Felber, H Paskalis, C Kleinman-Ewing, F Wong-Staal, and G. Pavlakis (1985)
Science 229, 675-679
   Abstract »    PDF »
Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.
S Harada, Y Koyanagi, and N Yamamoto (1985)
Science 229, 563-566
   Abstract »    PDF »
cis- and trans-acting transcriptional regulation of visna virus.
J. Hess, J. Clements, and O Narayan (1985)
Science 229, 482-485
   Abstract »    PDF »
Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).
S. Arya, C Guo, S. Josephs, and F Wong-Staal (1985)
Science 229, 69-73
   Abstract »    PDF »
Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.
J Sodroski, R Patarca, C Rosen, F Wong-Staal, and W Haseltine (1985)
Science 229, 74-77
   Abstract »    PDF »
A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus.
J Sodroski, C Rosen, W. Goh, and W Haseltine (1985)
Science 228, 1430-1434
   Abstract »    PDF »
Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.
J. Allan, J. Coligan, F Barin, M. McLane, J. Sodroski, C. Rosen, W. Haseltine, T. Lee, and M Essex (1985)
Science 228, 1091-1094
   Abstract »    PDF »
Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells.
C. Rosen, J. Sodroski, R Kettman, A Burny, and W. Haseltine (1985)
Science 227, 320-322
   Abstract »    PDF »
More progress on the HTLV family.
J. Marx (1985)
Science 227, 156-157
   PDF »
Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus.
M. Gonda, F Wong-Staal, R. Gallo, J. Clements, O Narayan, and R. Gilden (1985)
Science 227, 173-177
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)